SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-093900
Filing Date
2022-04-01
Accepted
2022-04-01 17:29:03
Documents
12
Period of Report
2022-04-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d326403d8k.htm   iXBRL 8-K 28654
  Complete submission text file 0001193125-22-093900.txt   151564

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rxdx-20220401.xsd EX-101.SCH 2898
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxdx-20220401_lab.xml EX-101.LAB 17978
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxdx-20220401_pre.xml EX-101.PRE 11286
6 EXTRACTED XBRL INSTANCE DOCUMENT d326403d8k_htm.xml XML 3353
Mailing Address 3050 SCIENCE PARK ROAD SAN DIEGO CA 92121
Business Address 3050 SCIENCE PARK ROAD SAN DIEGO CA 92121 (858) 422-4300
Prometheus Biosciences, Inc. (Filer) CIK: 0001718852 (see all company filings)

IRS No.: 814282653 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40187 | Film No.: 22799526
SIC: 2834 Pharmaceutical Preparations